IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 77 filers reported holding IGM BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,061 | -9.5% | 2,522,244 | 0.0% | 0.90% | +25.2% |
| Q2 2023 | $23,280 | -32.5% | 2,522,244 | +0.5% | 0.72% | -64.8% |
| Q1 2023 | $34,487 | -18.9% | 2,509,972 | +0.4% | 2.05% | -13.7% |
| Q4 2022 | $42,526 | -99.9% | 2,500,000 | 0.0% | 2.37% | -2.2% |
| Q3 2022 | $56,850,000 | +53.8% | 2,500,000 | +22.0% | 2.43% | +22.9% |
| Q2 2022 | $36,962,000 | -30.9% | 2,050,000 | +2.5% | 1.97% | -11.8% |
| Q1 2022 | $53,460,000 | +21.5% | 2,000,000 | +33.3% | 2.24% | +87.4% |
| Q4 2021 | $43,995,000 | -50.4% | 1,500,000 | +11.1% | 1.19% | -39.9% |
| Q3 2021 | $88,776,000 | -3.0% | 1,350,000 | +22.7% | 1.99% | +6.9% |
| Q2 2021 | $91,520,000 | +6.1% | 1,100,000 | -2.2% | 1.86% | +21.9% |
| Q1 2021 | $86,276,000 | -18.6% | 1,125,000 | -6.2% | 1.52% | -33.0% |
| Q4 2020 | $105,948,000 | +108.4% | 1,200,000 | +74.2% | 2.27% | +84.3% |
| Q3 2020 | $50,848,000 | +788.3% | 688,910 | +359.3% | 1.23% | +458.4% |
| Q4 2019 | $5,724,000 | +61.2% | 150,000 | -25.0% | 0.22% | +55.6% |
| Q3 2019 | $3,550,000 | – | 200,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $97,797,000 | 2.22% |
| Artal Group S.A. | 1,500,000 | $43,995,000 | 1.19% |
| Cormorant Asset Management, LP | 500,000 | $14,665,000 | 0.87% |
| Eagle Bay Advisors LLC | 34,835 | $1,022,000 | 0.65% |
| ENTRUST GLOBAL PARTNERS L L C | 66,172 | $1,940,000 | 0.54% |
| Baker Brothers Advisors | 3,156,102 | $92,568,000 | 0.45% |
| Bruce & Co., Inc. | 55,000 | $1,613,000 | 0.32% |
| Woodline Partners LP | 403,401 | $11,832,000 | 0.17% |
| Virtus ETF Advisers LLC | 5,787 | $170,000 | 0.06% |
| Alkeon Capital Management | 939,035 | $27,542,000 | 0.05% |